Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 May 26;16(6):184. doi: 10.3390/md16060184

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Effect of MAG-DHA on expression levels of circulating IL-6 in CF patients. (A) IL-6 levels were assessed using specific ELISA in plasma of healthy subjects (n = 6) and CF patients of placebo group before (n = 5) and after 30 (n = 5) and 60 days (n = 2) of supplementation. (B) IL-6 levels in plasma of healthy subjects (n = 6) and CF patients of MAG-DHA group before (n = 6) and after 30 (n = 6) and 60 days (n = 3) of daily supplementation. (C) Bar graph displaying changes in IL-6 levels after 30 days of placebo (n = 5) or MAG-DHA (n = 6) daily intake in CF patients. (D) Bar graph displaying changes in IL-6 levels after 60 days of placebo (n = 2) or MAG-DHA (n = 3) supplementation CF patients. Results are expressed as means ± SEM, * p ≤ 0.05.